EyePoint Pharmaceuticals Inc. buy Cantor Fitzgerald
Start price
14.09.23
/
50%
€10.20
Target price
14.09.24
€29.02
Performance (%)
-18.55%
End price
15.09.24
€8.31
Summary
This prediction ended on 15.09.24 with a price of €8.31. The prediction for EyePoint Pharmaceuticals Inc. disappointed with a performance of -18.55%. Cantor_Fitzgerald has a follow-up prediction for EyePoint Pharmaceuticals Inc. where he still thinks EyePoint Pharmaceuticals Inc. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | 5.310% | 5.310% | 45.157% |
| iShares Core DAX® | -1.779% | 2.475% | 1.471% |
| iShares Nasdaq 100 | 1.522% | 3.290% | 33.721% |
| iShares Nikkei 225® | 1.083% | 7.039% | 59.258% |
| iShares S&P 500 | 0.929% | 3.254% | 24.730% |
Comments by Cantor_Fitzgerald for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $31.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€12.20
08.07.26
08.07.26
€41.17
08.07.27
08.07.27
6.56%
08:55
08:55
Stopped prediction by Cantor_Fitzgerald for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.48
20.06.24
20.06.24
-
20.06.25
20.06.25
-6.79%
21.06.25
21.06.25
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.00
31.08.23
31.08.23
€28.59
31.08.24
31.08.24
-13.24%
01.09.24
01.09.24